CVE-2012-3188
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft Products 8.50 and 8.51 allows remote authenticated users to affect integrity, related to PIA Core Technology.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft Products 8.50 and 8.51 allows remote authenticated users to affect integrity, related to PIA Core Technology.
- Record
CVE-2012-3188- CVSS 2.0
- 3.5 Low
AV:N/AC:M/Au:S/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft Products 8.50 and 8.51 allows remote authenticated users to affect integrity, related to PIA Core Technology.
- Record
CVE-2012-3188- Updated
- 2026-11-02
EUVDEUVD-2012-3166 No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft Products 8.50 and 8.51 allows remote authenticated users to affect integrity, related to PIA Core Technology.
- Record
EUVD-2012-3166- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-xrjj-hqhj-84h2 No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft Products 8.50 and 8.51 allows remote authenticated users to affect integrity, related to PIA Core Technology.
- Record
GHSA-xrjj-hqhj-84h2- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2012-3188 is a low vulnerability (CVSS 3.5) in Oracle Peoplesoft Products, published October 17, 2012. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.00%, the 62nd percentile. No source names a fixed version.